EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators

Marcus Svedberg iD, Frida Lundqvist, Huda Abdulahi Östrand, Christina Krantz, Per Ekman, Henrik Imberg iD

Acta Paediatrica · 2026-06 · 115 (6) · 1283-1289

DOI: 10.1111/apa.70498 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Paediatrica, online erschienen am 11.03.2026. Verfasst von Marcus Svedberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quality of Life, Quinolones, Aminophenols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Drottning Silvias barnsjukhus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Children with cystic fibrosis (CF) face substantial daily treatment burdens and the effects of transmembrane conductance regulator modulators on these have not been sufficiently described. We evaluated changes in treatment burden after elexacaftor tezacaftor ivacaftor (ETI) was initiated.

Methods

This prospective observational study comprised children aged six to 17 years from three Swedish paediatric CF centres. They were enrolled from 7 December 2022 to 30 June 2023, before ETI was initiated. Their health‐related quality of life, treatment burden, and adherence were assessed at baseline and at six and 12 months.

Results

We studied 62 children who initiated ETI and were followed up to 12 months. The mean standard deviation (SD) treatment burden score improved by 4.9 points (95% confidence interval (CI) −0.7 to 10.6, p = 0.087), from 67.6 (±20.6) at baseline to 72.5 (±17.6) at 12 months. The mean daily time spent on inhalation therapy and airway clearance decreased from 91.9 (±37.3) to 70.4 (±23.6) minutes ( p < 0.001). Mean inhalation time per session fell by 7 min (95% CI −10.5 to −3.3, p < 0.001) and airway clearance time by 4 min (95% CI −6.7 to −1.5, p = 0.003).

Conclusion

Treatment burden, particularly daily inhalation and airway clearance time, decreased after ETI initiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisQuality of LifeQuinolonesAminophenolsIndolesHumansChildFemaleMaleProspective StudiesAdolescent

Stichwörter der Autor:innen

cystic fibrosiselexacaftor tezacaftor ivacaftorinhalation therapytransmembrane conductance regulator modulatorstreatment burden

Substanzen

QuinolonesAminophenolsIndoles

Autor:innen und Institutionen

  • Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
  • Department of Paediatrics, Queen Silvia's Children's Hospital, Gothenburg, Sweden.
  • Centre for Digital Health, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Paediatrics, Skåne University Hospital, Lund, Sweden.
  • Department of Paediatrics, Uppsala University Hospital, Uppsala, Sweden.
  • Statistiska Konsultgruppen Sweden, Gothenburg, Sweden.

ORCID-Profile: Marcus Svedberg, Henrik Imberg

Förderung

  • Drottning Silvias barnsjukhus

Zitieren

APA

Svedberg, M., Lundqvist, F., Östrand, H. A., Krantz, C., Ekman, P., & Imberg, H. (2026). Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators. Acta Paediatrica, 115(6), 1283-1289. https://doi.org/10.1111/apa.70498

Vancouver

Svedberg M, Lundqvist F, Östrand HA, Krantz C, Ekman P, Imberg H. Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators. Acta Paediatrica. 2026;115(6):1283-1289. doi:10.1111/apa.70498

BibTeX
@article{Svedberg2026,
  author = {Svedberg, Marcus and Lundqvist, Frida and Östrand, Huda Abdulahi and Krantz, Christina and Ekman, Per and Imberg, Henrik},
  title = {Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators},
  journal = {Acta Paediatrica},
  year = {2026},
  volume = {115},
  number = {6},
  pages = {1283--1289},
  doi = {10.1111/apa.70498}
}
Kostenlos starten →